BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9066353)

  • 21. The role of MRI in the diagnosis of multiple sclerosis.
    Traboulsee AL; Li DK
    Adv Neurol; 2006; 98():125-46. PubMed ID: 16400831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in adhesion molecules in cerebrospinal fluid of children with mumps and mumps meningitis.
    Sulik A; Wojtkowska M; Rozkiewicz D; Oldak E
    Scand J Immunol; 2006 Oct; 64(4):420-4. PubMed ID: 16970684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble adhesion molecules in acute ischemic stroke.
    Simundic AM; Basic V; Topic E; Demarin V; Vrkic N; Kunovic B; Stefanovic M; Begonja A
    Clin Invest Med; 2004 Apr; 27(2):86-92. PubMed ID: 15202827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum soluble adhesion molecules in patients with sarcoidosis].
    Mukae H; Ashitani J; Ihiboshi H; Taniguchi H; Matsukura S; Iida K; Kadota J; Kohno S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1186-90. PubMed ID: 9493444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.
    Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P
    J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1.
    Droogan AG; McMillan SA; Douglas JP; Hawkins SA
    J Neuroimmunol; 1996 Feb; 64(2):185-91. PubMed ID: 8632061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
    Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The level of soluble forms of interleukin-2 receptor and adhesive molecules ICAM-1 and VCAM-1 in platelets of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Pol Merkur Lekarski; 1999 Jan; 6(31):23-6. PubMed ID: 10344149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
    Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
    Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
    Tortorella C; Bellacosa A; Paolicelli D; Fuiani A; Di Monte E; Simone IL; Giaquinto P; Livrea P; Trojano M
    J Neurol Sci; 2005 Dec; 239(1):95-9. PubMed ID: 16209877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis.
    Whitaker JN; Williams PH; Layton BA; McFarland HF; Stone LA; Smith ME; Kachelhofer RD; Bradley EL; Burgard S; Zhao G
    Ann Neurol; 1994 May; 35(5):577-85. PubMed ID: 7513981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
    J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of CXCL13 are elevated in active multiple sclerosis.
    Festa ED; Hankiewicz K; Kim S; Skurnick J; Wolansky LJ; Cook SD; Cadavid D
    Mult Scler; 2009 Nov; 15(11):1271-9. PubMed ID: 19805441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
    Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
    Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
    Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J
    J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis patients is unsialylated.
    Massaro AR; De Pascalis D; Carnevale A; Carbone G
    Eur Rev Med Pharmacol Sci; 2009; 13(5):397-9. PubMed ID: 19961048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity.
    Kraus J; Engelhardt B; Chatzimanolis N; Bauer R; Tofighi J; Kuehne BS; Laske C; Stolz E; Frielinghaus P; Schaefer C; Blaes F; Traupe H; Kaps M; Oschmann P
    J Neuroimmunol; 2002 Jan; 122(1-2):175-85. PubMed ID: 11777557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-CAM in cerebrospinal fluid: a marker of synaptic remodelling after acute phases of multiple sclerosis?
    Massaro AR; Albrechtsen M; Bock E
    Ital J Neurol Sci; 1987 Jun; Suppl 6():85-8. PubMed ID: 3654182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion molecules.
    Vora AJ; Kidd D; Miller DH; Perkin GD; Hughes RA; Ellis BA; Dumonde DC; Brown KA
    Mult Scler; 1997 Jun; 3(3):171-9. PubMed ID: 9310962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.